An open-label, single-centered, non-randomized trial of inosine to assess its safety for patients with Parkinson's disease

Trial Profile

An open-label, single-centered, non-randomized trial of inosine to assess its safety for patients with Parkinson's disease

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Aug 2016

At a glance

  • Drugs Inosine (Primary)
  • Indications Parkinson's disease
  • Focus Adverse reactions
  • Most Recent Events

    • 03 Aug 2016 Status changed from recruiting to completed.
    • 19 Oct 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top